|
| Press Releases |
|
 |
|
| Friday, April 9, 2021 |
|
|
Deltacore Capital launches Deltacore Digital Global LP |
| Deltacore Capital LLC, the firm that manages Deltacore Digital Assets LP, a hedge fund that specializes in digital assets, has announced Deltacore Digital Global LP, a 506(c) overseas fund offering for international clients who wish to access Deltacore's proprietary investment strategy. more info >> |
|
| Wednesday, April 7, 2021 |
|
|
Deltacore Capital, LLC launches Deltacore Digital Global LP |
| Deltacore Capital, LLC, the firm behind Deltacore Digital Assets LP, a US-based hedge fund specialized in trading digital assets, announced the launch of Deltacore Digital Global LP, an international 506(c) hedge fund offering for international clients to gain access to Deltacore's proprietary investment strategy, which has yielded 560.9% since its US inception in April, 2018. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
在 2026 年 Gartner(R)《供應鏈規劃解決方案：流程工業》魔力象限(TM) 報告中，OMP 在「願景完整性」與「執行能力」兩大指標上均位居首位
Mar 23, 2026 23:15 HKT/SGT
|
|
|
在2026年Gartner(R)《供应链规划解决方案魔力象限(TM)：流程工业》报告中，OMP在“愿景完整性”和“执行能力”两项指标上均位居最高位置
Mar 23, 2026 23:15 HKT/SGT
|
|
|
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries
Mar 23, 2026 23:15 HKT/SGT
|
|
|
Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書，以評估收購 Neuritek Therapeutics, Inc. 的可能性；該公司致力於開發治療神經系統及精神疾病的創新療法
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share
Mar 23, 2026 20:51 HKT/SGT
|
|
|
億勝生物科技2025全年業績穩健 收入升8.6%至18.14億港元 淨利潤升3.5%至3.18億港元 全年股息增加16.7%至每股14港仙
Mar 23, 2026 20:37 HKT/SGT
|
|
|
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe
Mar 23, 2026 20:29 HKT/SGT
|
|
|
亿胜生物科技2025全年业绩稳健 收入升8.6%至18.14亿港元 净利润升3.5%至3.18亿港元 全年股息增加16.7%至每股14港仙
Mar 23, 2026 20:13 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 23, 2026 18:59 HKT/SGT
|
|
|
雲頂新耀達成艾曲帕米鼻噴霧劑資產收購協議 強化心血管領域產品佈局
Mar 23, 2026 18:59 HKT/SGT
|
|
|
云顶新耀达成艾曲帕米鼻喷雾剂资产收购协议 强化心血管领域产品布局
Mar 23, 2026 18:59 HKT/SGT
|
|
|
同仁堂医养（02667.HK）新股招股：尚在发展早期的中医医疗龙头股 估值几何？
Mar 23, 2026 16:21 HKT/SGT
|
|
|
同仁堂醫養（02667.HK）新股招股：尚在發展早期的中醫醫療龍頭股 估值幾何？
Mar 23, 2026 16:21 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
